Related Experiment Video
Updated: Aug 15, 2026

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
Intraprostatic blood-flow changes during ProstaLund feedback treatment measured by positron emission tomography
Lennart Wagrell1, Anders Sundin, Bojohan Norlén
1Department of Urology, University Hospital Uppsala, Uppsala, Sweden. lewabi@telia.com
Purpose:
To investigate the changes in intraprostatic blood flow during ProstaLund Feedback Treatment (PLFT) using positron emission tomography (PET).
Patients And Methods:
Three patients with bladder outlet obstruction caused by benign prostatic hyperplasia were treated with PLFT using the ProstaLund device, which has the ability to calculate the intraprostatic blood flow. Treatment was given for 1 hour. Five PET scans were done during each treatment to calculate the three-dimensional blood flow using [(15)O]H(2)O as the tracer.
Results:
The prostatic blood flow increased steeply at the beginning of the treatment in all three patients, by as much as 100% at 20 and 35 minutes. For patients 1 and 2, there was a fast decline in intraprostatic flow at the last scan (55 minutes), clearly seen as a large zone with circulation arrest centrally in the prostate. The intraprostatic temperature was <50 degrees C during the first 30 minutes but increased to 52 degrees to 60 degrees C during the second part of the treatment. Patient 3 had high blood flow during the entire treatment. A reduction of the blood flow was seen at the end of the treatment but not to the same extent as in the other two patients. The intraprostatic temperature did not exceed 49 degrees C for this patient.
Conclusion:
The large variations seen in intraprostatic blood flow suggest that intraprostatic temperature monitoring is mandatory to optimize the treatment. The ProstaLund bioheat model calculates the change in intraprostatic blood flow accurately.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...